Best treatments for accelerated phase myeloid leukemia
3 products may treat accelerated phase myeloid leukemia, spanning FDA drug classes such as kinase inhibitor. The current highest-rated option is danziten. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 3 drugs we list for accelerated phase myeloid leukemia, none are yet flagged as generics in our price data, spanning classes such as kinase inhibitor. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for accelerated phase myeloid leukemia — so confirm the right choice with your prescriber.
Top-rated picks for accelerated phase myeloid leukemia: 1. Danziten · 2. Tasigna · 3. Cavhanza
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 70/100 | Prescription | Tablet | Kinase Inhibitor | No data | — | View → | |
| 2 | 70/100 | Prescription | Capsule | Kinase Inhibitor | No data | — | View → | |
| 3 | Not yet rated | Prescription | Tablet | Kinase Inhibitor | No data | — | View → |
Narrow by drug class
Explore the class hubs: kinase inhibitor
Full ranking · 3 treatments
danziten
Boxed warningPrescriptionFDA-sourced
Danziten (Nilotinib Tartrate) is a kinase inhibitor used to treat Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors.
Price varies
tasigna
Boxed warningPrescriptionFDA-sourced
Tasigna (Nilotinib Hydrochloride) is a kinase inhibitor used to treat Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia.
Price varies
cavhanza
PrescriptionFDA-sourced
Cavhanza (Nilotinib) is a kinase inhibitor used to treat Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors.
Price varies
Frequently asked
- What treats accelerated phase myeloid leukemia?
- Our catalog lists 3 products that may treat accelerated phase myeloid leukemia, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is danziten.
- What is the best-rated treatment for accelerated phase myeloid leukemia?
- By our independent recall-safety rating — not an efficacy measure — danziten ranks highest among the products we list for accelerated phase myeloid leukemia. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat accelerated phase myeloid leukemia?
- Treatments for accelerated phase myeloid leukemia span FDA drug classes including kinase inhibitor. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.